Bio-Rad Labs Inc. A buy UBS Group AG
Start price
08.05.24
/
50%
€248.20
Target price
08.05.25
€357.93
Performance (%)
6.49%
Price
24.06.24
€264.30
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 6.49%. This prediction currently runs until 08.05.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Bio-Rad Labs Inc. A | -4.100% | -4.100% |
iShares Core DAX® | 0.410% | -2.543% |
iShares Nasdaq 100 | -2.154% | 4.721% |
iShares Nikkei 225® | -0.066% | -0.307% |
iShares S&P 500 | -0.527% | 3.848% |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at UBS Group AG from $420.00 to $385.00. They now have a "buy" rating on the stock.
Ratings data for BIO provided by MarketBeat
Stopped prediction by UBS_Group_AG for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€316.20
16.02.24
16.02.24
€389.51
16.02.25
16.02.25
-16.41%
24.06.24
24.06.24
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€285.60
07.12.23
07.12.23
€365.97
07.12.24
07.12.24
-7.46%
24.06.24
24.06.24